Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/μl

被引：20

作者：

Mussini, C ^{[1
]}

Bugarini, R

Perno, CF

Antinori, A

Borghi, V

Bertoli, A

D'Arrigo, R

Bedini, A

Mongiardo, N

Cossarizza, A

Esposito, R

机构：

[1] Univ Modena, Clin Infect & Trop Dis, I-41100 Modena, Italy

[2] Azienda Policlin, I-41100 Modena, Italy

[3] Ist Super Sanita, I-00161 Rome, Italy

[4] IRCCS, Natl Inst Infect Dis L Spallanzani, Rome, Italy

[5] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy

来源：

AIDS | 2002年 / 16卷 / 11期

关键词：

D O I：

10.1097/00002030-200207260-00013

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

After a median of 37 months on antiretroviral therapy, 16 patients were asked to discontinue treatment instead of changing it. After a median observation time of 10.5 months, most patients experienced a rapid and progressive decrease in their CD4 cell count, even without a high viral load rebound. This decline was unrelated to the CD4 cell count and HIV-RNA values at interruption, but was more profound in patients in whom the M184V mutation had disappeared after lamivudine discontinuation.

引用

页码：1551 / 1554

页数：4

共 50 条

[31] CD4 Count Recovery After Initiation of Antiretroviral Therapy in Patients Infected With Human Immunodeficiency Virus
Bishop, Johnathon Drake
DeShields, Sarah
Cunningham, Tina
Troy, Stephanie B.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 352 (03): : 239 - 244
[32] CD4 COUNT AND THE RISK FOR DEATH IN PATIENTS INFECTED WITH HIV RECEIVING ANTIRETROVIRAL THERAPY
YARCHOAN, R
VENZON, DJ
PLUDA, JM
LIETZAU, J
WYVILL, KM
TSIATIS, AA
STEINBERG, SM
BRODER, S
ANNALS OF INTERNAL MEDICINE, 1991, 115 (03) : 184 - 189
[33] ANTI-CD4 PREFERENTIALLY ELIMINATES NAIVE CD4 CELLS AND SPARES PREACTIVATED CD4 CELLS
FIELD, EH
CHACE, JH
COWDERY, JS
ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S47 - S47
[34] CD4 T cell cooperation is required for the in vivo activation of CD4 T cells
Peters, Nathan C.
Kroeger, David R.
Mickelwright, Steven
Bretscher, Peter A.
INTERNATIONAL IMMUNOLOGY, 2009, 21 (11) : 1213 - 1224
[35] Nevirapine versus efavirenz in 742 patients:: no link of liver toxicity with female sex, and a baseline CD4 cell count greater than 250 cells/μl
Manfredi, Roberto
Calza, Leonardo
AIDS, 2006, 20 (17) : 2233 - 2236
[36] Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200cells/μL in British Columbia, Canada
Lourenco, L.
Samji, H.
Nohpal, A.
Chau, W.
Colley, G.
Lepik, K.
Barrios, R.
Lima, V.
Hogg, R. S.
Montaner, J. S. G.
Kesselring, S.
Moore, D. M.
HIV MEDICINE, 2015, 16 (06) : 337 - 345
[37] STUDY OF CD4 COUNT IN HIV PATIENTS ON HAART THERAPY
Vemula, Sreenivasulu
Rao, Venkateswara K. S. S.
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (95): : 7034 - 7041
[38] Effect of patient smoking status on CD4 count change after initiation of antiretroviral therapy
Lodwick, R.
Johnson, M.
Smith, C.
Lipman, M.
Cambiano, V.
Tyrer, M.
Phillips, A.
Lampe, F.
HIV MEDICINE, 2012, 13 : 73 - 73
[39] Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy
Staszewski, S
Miller, V
Sabin, C
Schlecht, C
Gute, P
Stamm, S
Leder, T
Berger, A
Weidemann, E
Hill, A
Phillips, A
AIDS, 1999, 13 (08) : 951 - 956
[40] Early Postseroconversion CD4 Cell Counts Independently Predict CD4 Cell Count Recovery in HIV-1-Postive Subjects Receiving Antiretroviral Therapy
Kulkarni, Hemant
Okulicz, Jason F.
Grandits, Greg
Crum-Cianflone, Nancy F.
Landrum, Michael L.
Hale, Braden
Wortmann, Glenn
Tramont, Edmund
Polis, Michael
Dolan, Matthew
Lifson, Alan R.
Agan, Brian K.
Ahuja, Sunil K.
Marconi, Vincent C.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 57 (05) : 387 - 395

← 1 2 3 4 5 →